156. Adulteration   and   misbranding   of   Elixir   Sodium   Salicylate   Compound.
V.   S.  v.   Standard  Plsarmacal  Co.     Plea  of  nolo  contendere.    Fine,  $25.
(F. D. C. No. 956.    Sample No. 55545-D.)
This product was represented to be a drug the name of which is recognized
in the National Formulary. It contained potassium iodide in excess of the
amount specified in the National Formulary, and in excess of the amount
declared on its label.
On May 14, 1940, the United States attorney for the Northern District of
Illinois filed an information against the Standard Pharmacal Co., a corporation,
Chicago, 111., alleging shipment by said company on or about July 31, 1939, from
the State of Illinois into the State of Indiana, of a quantity of elixir sodium
salicylate compound which was adulterated and misbranded.
Adulteration was alleged in that the article was represented as a drug the
name of which i& recognized in an official compendium, the National Formulary,
and its strength differed from the standard set forth in said compendium in
that 1,000 cubic centimeters of the article contained not less than 20.2 grams
of potassium iodide, equivalent to 9.19 grains per fluid ounce; whereas the
National Formulary provides that compound elixir of sodium salicylate shall
contain in each 1,000 cubic centimeters 15 grams of potassium iodide, equivalent
to 6.84 grains per fluid ounce and the difference in strength of the article from
the said standard was not stated plainly on the label.
Misbranding was alleged in that the representation on the label that each fluid
ounce represented 3? grains of potassium iodide was false and misleading since
each fluid ounce of the article contained not less than 9.19 grains of potassium
iodide.
On June 24, 1940, a plea of nolo contendere was entered on behalf of the
defendant, and the court imposed a fine of $25.